1 Market Overview
1.1 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
1.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast
1.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Trends & Drivers
1.3.1 Point-of-Care Infectious Disease Diagnostics & Testing Industry Trends
1.3.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers & Opportunity
1.3.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Challenges
1.3.4 Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Players Revenue Ranking (2024)
2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Company (2019-2025)
2.3 Key Companies Point-of-Care Infectious Disease Diagnostics & Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Point-of-Care Infectious Disease Diagnostics & Testing
2.6 Point-of-Care Infectious Disease Diagnostics & Testing Market Competitive Analysis
2.6.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Rate (2019-2025)
2.6.2 Global 5 and 10 Largest Companies by Point-of-Care Infectious Disease Diagnostics & Testing Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Infectious Disease Diagnostics & Testing as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 HIV POC
3.1.2 Clostridium difficile POC
3.1.3 HBV POC
3.1.4 Pneumonia or Streptococcus associated infections
3.1.5 Respiratory syncytial virus (RSV) POC
3.1.6 HPV POC
3.1.7 Influenza/Flu POC
3.1.8 Other Infectious Disease POC
3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Type
3.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Type (2019 VS 2024 VS 2034)
3.2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, by Type (2019-2034)
3.2.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, by Type (%) (2019-2034)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Home
4.1.4 Assisted Living Healthcare Facilities
4.1.5 Laboratories
4.1.6 Others
4.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Application
4.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Application (2019 VS 2024 VS 2034)
4.2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, by Application (2019-2034)
4.2.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, by Application (%) (2019-2034)
5 Segmentation by Region
5.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Region
5.1.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Region: 2019 VS 2024 VS 2034
5.1.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Region (2019-2025)
5.1.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Region (2025-2034)
5.1.4 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Region (%), (2019-2034)
5.2 North America
5.2.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
5.2.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Country (%), 2024 VS 2034
5.3 Europe
5.3.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
5.3.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Country (%), 2024 VS 2034
5.4 Asia Pacific
5.4.1 Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
5.4.2 Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Country (%), 2024 VS 2034
5.5 South America
5.5.1 South America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
5.5.2 South America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Country (%), 2024 VS 2034
5.6 Middle East & Africa
5.6.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
5.6.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Country (%), 2024 VS 2034
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Growth Trends, 2019 VS 2024 VS 2034
6.2 Key Countries/Regions Point-of-Care Infectious Disease Diagnostics & Testing Sales Value
6.3 United States
6.3.1 United States Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
6.3.2 United States Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Type (%), 2024 VS 2034
6.3.3 United States Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Application, 2024 VS 2034
6.4 Europe
6.4.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
6.4.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Type (%), 2024 VS 2034
6.4.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Application, 2024 VS 2034
6.5 China
6.5.1 China Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
6.5.2 China Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Type (%), 2024 VS 2034
6.5.3 China Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Application, 2024 VS 2034
6.6 Japan
6.6.1 Japan Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
6.6.2 Japan Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Type (%), 2024 VS 2034
6.6.3 Japan Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Application, 2024 VS 2034
6.7 South Korea
6.7.1 South Korea Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
6.7.2 South Korea Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Type (%), 2024 VS 2034
6.7.3 South Korea Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Application, 2024 VS 2034
6.8 Southeast Asia
6.8.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
6.8.2 Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Type (%), 2024 VS 2034
6.8.3 Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Application, 2024 VS 2034
6.9 India
6.9.1 India Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, 2019-2034
6.9.2 India Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Type (%), 2024 VS 2034
6.9.3 India Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Application, 2024 VS 2034
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.1.4 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.1.5 Abbott Recent Developments
7.2 Thermo Fisher Scientific Inc
7.2.1 Thermo Fisher Scientific Inc Profile
7.2.2 Thermo Fisher Scientific Inc Main Business
7.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.2.5 Thermo Fisher Scientific Inc Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.3.4 Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.3.5 Siemens Healthineers Recent Developments
7.4 Siemens Healthineers
7.4.1 Siemens Healthineers Profile
7.4.2 Siemens Healthineers Main Business
7.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.4.4 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.4.5 Siemens Healthineers Recent Developments
7.5 BD & Company
7.5.1 BD & Company Profile
7.5.2 BD & Company Main Business
7.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.5.4 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.5.5 BD & Company Recent Developments
7.6 Chembio Diagnostics Inc.
7.6.1 Chembio Diagnostics Inc. Profile
7.6.2 Chembio Diagnostics Inc. Main Business
7.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.6.4 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.6.5 Chembio Diagnostics Inc. Recent Developments
7.7 Trinity Biotech
7.7.1 Trinity Biotech Profile
7.7.2 Trinity Biotech Main Business
7.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.7.4 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.7.5 Trinity Biotech Recent Developments
7.8 Cardinal Health
7.8.1 Cardinal Health Profile
7.8.2 Cardinal Health Main Business
7.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.8.4 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.8.5 Cardinal Health Recent Developments
7.9 Quest Diagnostics Inc.
7.9.1 Quest Diagnostics Inc. Profile
7.9.2 Quest Diagnostics Inc. Main Business
7.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.9.4 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.9.5 Quest Diagnostics Inc. Recent Developments
7.10 Bio-Rad Labs Inc.
7.10.1 Bio-Rad Labs Inc. Profile
7.10.2 Bio-Rad Labs Inc. Main Business
7.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.10.4 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.10.5 Bio-Rad Labs Inc. Recent Developments
7.11 bioMérieux SA
7.11.1 bioMérieux SA Profile
7.11.2 bioMérieux SA Main Business
7.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.11.4 bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.11.5 bioMérieux SA Recent Developments
7.12 Sight Diagnostics Ltd.
7.12.1 Sight Diagnostics Ltd. Profile
7.12.2 Sight Diagnostics Ltd. Main Business
7.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.12.4 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.12.5 Sight Diagnostics Ltd. Recent Developments
7.13 Gene POC
7.13.1 Gene POC Profile
7.13.2 Gene POC Main Business
7.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.13.4 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.13.5 Gene POC Recent Developments
7.14 Trivitron Healthcare
7.14.1 Trivitron Healthcare Profile
7.14.2 Trivitron Healthcare Main Business
7.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.14.4 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.14.5 Trivitron Healthcare Recent Developments
7.15 OJ-Bio Ltd.
7.15.1 OJ-Bio Ltd. Profile
7.15.2 OJ-Bio Ltd. Main Business
7.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.15.4 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.15.5 OJ-Bio Ltd. Recent Developments
7.16 Ortho-Clinical Diagnostics
7.16.1 Ortho-Clinical Diagnostics Profile
7.16.2 Ortho-Clinical Diagnostics Main Business
7.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Products, Services and Solutions
7.16.4 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue (US$ Million) & (2019-2025)
7.16.5 Ortho-Clinical Diagnostics Recent Developments
8 Industry Chain Analysis
8.1 Point-of-Care Infectious Disease Diagnostics & Testing Industrial Chain
8.2 Point-of-Care Infectious Disease Diagnostics & Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Point-of-Care Infectious Disease Diagnostics & Testing Sales Model
8.5.2 Sales Channel
8.5.3 Point-of-Care Infectious Disease Diagnostics & Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
